These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 15097043)

  • 1. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
    Rosaida MS; Goh KL
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
    Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
    Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all.
    Rajendra S; Kutty K; Karim N
    Dig Dis Sci; 2004 Feb; 49(2):237-42. PubMed ID: 15104363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
    Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
    Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients.
    Rezailashkajani M; Roshandel D; Shafaee S; Zali MR
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):499-506. PubMed ID: 17489061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
    Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
    Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.
    Martinez SD; Malagon IB; Garewal HS; Cui H; Fass R
    Aliment Pharmacol Ther; 2003 Feb; 17(4):537-45. PubMed ID: 12622762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia.
    Dore MP; Pes GM; Bassotti G; Farina MA; Marras G; Graham DY
    Scand J Gastroenterol; 2016 Nov; 51(11):1281-7. PubMed ID: 27381266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease.
    Wu JC; Sung JJ; Chan FK; Ching JY; Ng AC; Go MY; Wong SK; Ng EK; Chung SC
    Aliment Pharmacol Ther; 2000 Apr; 14(4):427-32. PubMed ID: 10759622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the diagnosis and management of GORD in adults.
    Hopper AD
    Practitioner; 2015 Apr; 259(1781):27-32, 3. PubMed ID: 26529827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and gastro-oesophageal reflux disease: a cross-sectional epidemiological study.
    Loffeld RJ; van der Putten AB
    Neth J Med; 2004 Jun; 62(6):188-91. PubMed ID: 15460497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea.
    Kim N; Lee SW; Cho SI; Park CG; Yang CH; Kim HS; Rew JS; Moon JS; Kim S; Park SH; Jung HC; Chung IS;
    Aliment Pharmacol Ther; 2008 Jan; 27(2):173-85. PubMed ID: 17973646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.
    Roman S; Kahrilas PJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):17-28. PubMed ID: 25743453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients.
    Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Seripa D; Perri F; Niro V; Paris F; Andriulli A; Di Mario F
    J Am Geriatr Soc; 2006 Oct; 54(10):1537-42. PubMed ID: 17038071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
    Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
    Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus.
    Laheij RJ; Van Rossum LG; De Boer WA; Jansen JB
    Aliment Pharmacol Ther; 2002 May; 16(5):887-91. PubMed ID: 11966496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy.
    Loffeld RJ; van der Putten AB
    Digestion; 2003; 68(2-3):141-4. PubMed ID: 14646335
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.